Diligence memo · auto-generated · as of July 2, 2026
Proton Therapy USA, Inc.
Proton Therapy USA, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Proton Therapy USA, Inc. operates in Other Health Care, based in BOZEMAN.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Proton Therapy USA, Inc. has raised $6.7M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.0M on 2008-10-29.
Most recent recorded round closed around 2011-04-01.
Valuation (modeled)modeled
Provath models Proton Therapy USA, Inc. at approximately $25M (range $859K–$198M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.63× the median modeled value of Seed Other Health Care companies in 2010–2012 (243 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 15 months.
Last raise 15.3 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 2.7× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 69% of Other Health Care peers (5377 compared).
Modeled value ranks above 53% of those peers.
Closest niche peers: Coolsystems Inc, Device Innovation Group, LLC, Envoy Partners Llc, Kare Partners LLC, CuMed LLC.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.